Delivery Order SPE2DB25D9320-SPE2DB25FWEYN

Award Date 2/12/25
Potential Completion Date 3/6/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $1,126.98 and an ultimate completion date of August 30, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA...
This federal contract award is for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $6,680.52, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with an ultimate completion date of February 13, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of YF-VAX 1 DOSE VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $1,126.98 and an ultimate completion date of October 2, 2024. It is not associated with any set-aside designation. DMS Pharmaceutical Group holds a...
This federal contract award is for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA), a supply chain management agency within the Department of Defense (DoD). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $11,269.80 and a period of performance ending on December 13, 2024. This contract is not...
This contract award is for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA) under the Medical Supply Chain division, a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award has a ceiling value of $1,690.47 and is a firm fixed-price delivery order. The contract has no set-aside designation and is part of a larger indefinite delivery contract (IDC) with a...
This federal contract award is for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,126.98 and is a firm fixed-price delivery order. The contract covers the delivery of a variety of pharmaceutical products, including branded and generic prescription drugs,...
The federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,034.80 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, with a completion date of February 4, 2022. This award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This...
The federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,817.45 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, with an ultimate completion date of October 30, 2024. This award is under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31,...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $22,539.60, is to provide the YF-VAX 1 dose vials to the DLA. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the SPE2DB program, valued at up to $499,999,999, which runs through...
This federal contract award is for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA), a Defense agency. The contract was awarded on October 23, 2024 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Firm Fixed Price Delivery Order valued at $11,269.80 with a completion date of November 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by DMS...
  • SPE2DB25D9320
    Indefinite Delivery Contract
  • SPE2DB25D9320-SPE2DB25FWEYN
    Delivery Order

This federal contract award is for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $2,226.84 and an ultimate completion date of March 6, 2025. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This specific contract award is not associated with any set-aside designation.

Generated 5/14/25, 10:02 AM